Title |
The dual role of tetraspanin CD63 in HIV-1 replication
|
---|---|
Published in |
Virology Journal, February 2014
|
DOI | 10.1186/1743-422x-11-23 |
Pubmed ID | |
Authors |
Guangyu Li, Mark A Endsley, Anoma Somasunderam, Sonia L Gbota, Maryann I Mbaka, James L Murray, Monique R Ferguson |
Abstract |
Previously, we showed that the tetraspanin membrane protein CD63 mediates both early and post-integration stages of the HIV-1 replication cycle. The temporal roles of CD63 were discerned using monoclonal antibodies and small interfering RNAs (siRNAs) to block CD63 function, and determining which of the sequential steps in HIV-1 replication were disrupted. Inhibition was shown to occur during early infection, suggestive of involvement in virus entry or reverse transcription. In addition, we have shown that treatment with CD63 siRNA post-infection, significantly inhibited virus production in supernatant, suggesting an important role for CD63 in macrophages during HIV-1 replication events occurring after proviral integration, and possibly during egress. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 1 | 20% |
Unknown | 4 | 80% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 80% |
Science communicators (journalists, bloggers, editors) | 1 | 20% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 3% |
United States | 1 | 3% |
Portugal | 1 | 3% |
Unknown | 30 | 91% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 11 | 33% |
Student > Bachelor | 5 | 15% |
Researcher | 3 | 9% |
Student > Master | 3 | 9% |
Student > Doctoral Student | 2 | 6% |
Other | 4 | 12% |
Unknown | 5 | 15% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 12 | 36% |
Biochemistry, Genetics and Molecular Biology | 5 | 15% |
Immunology and Microbiology | 3 | 9% |
Medicine and Dentistry | 3 | 9% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 6% |
Other | 3 | 9% |
Unknown | 5 | 15% |